80 FR 79900 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 246 (December 23, 2015)

Page Range		79900-79900
FR Document		2015-32212

Federal Register, Volume 80 Issue 246 (Wednesday, December 23, 2015)

[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Page 79900]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-32212]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to PAR 15-361, NIOSH Centers of Excellence for 
Total Worker Health.
    TIMES AND DATES: 8:00 a.m.-5:00 p.m., EST, March 16, 2016 (Closed).
    8:00 a.m.-5:00 p.m., EST, March 17, 2016 (Closed).
    PLACE: Hyatt Pittsburgh Airport, 1111 Airport Boulevard, 
Pittsburgh, Pennsylvania 15231.
    STATUS: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    MATTERS FOR DISCUSSION: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``PAR 15-361, NIOSH Centers of Excellence for Total Worker Health''.
    CONTACT PERSON FOR MORE INFORMATION: Nina Turner, Ph.D., Scientific 
Review Officer, NIOSH, CDC, 1095 Willowdale Road, Mailstop G905, 
Morgantown, West Virginia 26506, Telephone: (304) 285-5976.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-32212 Filed 12-22-15; 8:45 am]
BILLING CODE 4163-18-P

79900 Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices

objectives, strategies, and priorities of PLACE: Hyatt Pittsburgh Airport, Place: Teleconference.
NCHS. 1111 Airport Boulevard, Pittsburgh, Status: The meeting will be closed to
Matters for Discussion: The agenda Pennsylvania 15231. the public in accordance with
will include: STATUS: The meeting will be closed provisions set forth in section 552b(c)
1. Welcome remarks by the Director, to the public in accordance with (4) and (6), title 5 U.S.C., and the
NCHS provisions set forth in Section determination of the Director,
2. Presentation on ICD–10 552b(c)(4) and (6), Title 5 U.S.C., and Management Analysis and Services
3. Presentation on Health Interview the Determination of the Director, Office, CDC, pursuant to Public Law 92–
Survey Content Redesign Management Analysis and Services 463.
4. Update on Office of Analysis and Office, CDC, pursuant to Public Law 92– Matters for Discussion: The meeting
Epidemiology 463. will include the initial review,
5. Presentation on Web Survey MATTERS FOR DISCUSSION: The discussion, and evaluation of
meeting will include the initial review, applications received in response to
Requests to make oral presentations discussion, and evaluation of
should be submitted in writing to the ‘‘Research on the Epidemiology,
applications received in response to Vaccine Effectiveness and Treatment of
contact person listed below. All requests ‘‘PAR 15–361, NIOSH Centers of
must contain the name, address, Influenza and Other Respiratory Viruses
Excellence for Total Worker Health’’. in Southeast Asia and the Western
telephone number, and organizational CONTACT PERSON FOR MORE
affiliation of the presenter. Pacific’’, IP16–001 and ‘‘Annual
INFORMATION: Nina Turner, Ph.D., Estimates of Influenza Vaccine
Written comments should not exceed Scientific Review Officer, NIOSH, CDC,
five single-spaced typed pages in length Effectiveness for Preventing Medically
1095 Willowdale Road, Mailstop G905, Attended Laboratory-Confirmed
and must be received by December 31, Morgantown, West Virginia 26506,
2015. Influenza in the United States’’, IP16–
Telephone: (304) 285–5976. 002.
The agenda items are subject to The Director, Management Analysis
change as priorities dictate. Contact Person for More Information:
and Services Office, has been delegated
Contact Person For More Information: Gregory Anderson, M.S., M.P.H.,
the authority to sign Federal Register
Virginia S. Cain, Ph.D., Director of Scientific Review Officer, CDC, 1600
notices pertaining to announcements of
Extramural Research, NCHS/CDC, 3311 Clifton Road, NE., Mailstop E60,
meetings and other committee
Toledo Road, Room 7208, Hyattsville, Atlanta, Georgia 30333, Telephone:
management activities, for both the
Maryland 20782, telephone (301) 458– (404) 718–8833.
Centers for Disease Control and
4500, fax (301) 458–4024. Prevention and the Agency for Toxic The Director, Management Analysis
The Director, Management Analysis Substances and Disease Registry. and Services Office, has been delegated
and Services Office, has been delegated the authority to sign Federal Register
the authority to sign Federal Register Catherine Ramadei, notices pertaining to announcements of
notices pertaining to announcements of Acting Director, Management Analysis and meetings and other committee
meetings and other committee Services Office, Centers for Disease Control management activities, for both the
and Prevention. Centers for Disease Control and
management activities for both CDC and
the Agency for Toxic Substances and [FR Doc. 2015–32212 Filed 12–22–15; 8:45 am] Prevention and the Agency for Toxic
Disease Registry. BILLING CODE 4163–18–P Substances and Disease Registry.
Catherine Ramadei, Catherine Ramadei,
Acting Director, Management Analysis and DEPARTMENT OF HEALTH AND Acting Director, Management Analysis and
Services Office, Centers for Disease Control HUMAN SERVICES Services Office, Centers for Disease Control
and Prevention. and Prevention.
[FR Doc. 2015–32205 Filed 12–22–15; 8:45 am] Centers for Disease Control and [FR Doc. 2015–32206 Filed 12–22–15; 8:45 am]
BILLING CODE 4163–18–P Prevention BILLING CODE 4163–18–P

Disease, Disability, and Injury
DEPARTMENT OF HEALTH AND Prevention and Control Special DEPARTMENT OF HEALTH AND
HUMAN SERVICES Emphasis Panel (SEP): Initial Review HUMAN SERVICES
In accordance with section 10(a)(2) of Centers for Disease Control and
Centers for Disease Control and
the Federal Advisory Committee Act Prevention
Prevention
(Pub. L. 92–463), the Centers for Disease
Disease, Disability, and Injury Control and Prevention (CDC) Disease, Disability, and Injury
Prevention and Control Special announces a meeting for the initial Prevention and Control Special
Emphasis Panel (SEP): Initial Review review of applications in response to Emphasis Panel (SEP): Initial Review
Funding Opportunity Announcements
In accordance with Section 10(a)(2) of (FOA) IP16–001, Research on the In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act Epidemiology, Vaccine Effectiveness the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease and Treatment of Influenza and Other (Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) Respiratory Viruses in Southeast Asia Control and Prevention (CDC)
announces a meeting for the initial and the Western Pacific and (FOA) announces a meeting for the initial
tkelley on DSK3SPTVN1PROD with NOTICES

review of applications in response to IP16–002, Annual Estimates of review of applications in response to
PAR 15–361, NIOSH Centers of Influenza Vaccine Effectiveness for Funding Opportunity Announcement
Excellence for Total Worker Health. Preventing Medically Attended (FOA) CK16–001, Emerging Infections
TIMES AND DATES: 8:00 a.m.–5:00 Laboratory-Confirmed Influenza in the Sentinel Networks (EISN) Research.
p.m., EST, March 16, 2016 (Closed). United States. Time and Date: 10:00 a.m.–5:00 p.m.,
8:00 a.m.–5:00 p.m., EST, March 17, Time and Date: 10:00 a.m.–5:00 p.m., January 28, 2016 (Closed).
2016 (Closed). EST, February 24–25, 2016 (Closed). Place: Teleconference.

VerDate Sep<11>2014 18:05 Dec 22, 2015 Jkt 238001 PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1

Document Created: 2018-03-02 09:21:15
Document Modified: 2018-03-02 09:21:15

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		8:00 a.m.-5:00 p.m., EST, March 16, 2016 (Closed).
FR Citation		80 FR 79900

80 FR 79900 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 246 (December 23, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention